These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 1576669)
21. DX-9065a, a new synthetic, potent anticoagulant and selective inhibitor for factor Xa. Hara T; Yokoyama A; Ishihara H; Yokoyama Y; Nagahara T; Iwamoto M Thromb Haemost; 1994 Mar; 71(3):314-9. PubMed ID: 8029795 [TBL] [Abstract][Full Text] [Related]
22. Sodium orthovanadate inhibits p53-mediated apoptosis. Morita A; Yamamoto S; Wang B; Tanaka K; Suzuki N; Aoki S; Ito A; Nanao T; Ohya S; Yoshino M; Zhu J; Enomoto A; Matsumoto Y; Funatsu O; Hosoi Y; Ikekita M Cancer Res; 2010 Jan; 70(1):257-65. PubMed ID: 20048077 [TBL] [Abstract][Full Text] [Related]
23. The insulin-mimetic agent vanadate promotes receptor endocytosis and inhibits intracellular ligand-receptor degradation by a mechanism distinct from the lysosomotropic agents. Fantus IG; George R; Tang S; Chong P; Poznansky MJ Diabetes; 1996 Aug; 45(8):1084-93. PubMed ID: 8690156 [TBL] [Abstract][Full Text] [Related]
24. Biochemical characterization of a thrombin inhibitor from the bloodsucking bug Dipetalogaster maximus. Lange U; Keilholz W; Schaub GA; Landmann H; Markwardt F; Nowak G Haemostasis; 1999; 29(4):204-11. PubMed ID: 10702701 [TBL] [Abstract][Full Text] [Related]
25. Interaction of antistasin-related peptides with factor Xa: identification of a core inhibitory sequence. Ohta N; Brush M; Jacobs JW Thromb Haemost; 1994 Dec; 72(6):825-30. PubMed ID: 7740449 [TBL] [Abstract][Full Text] [Related]
26. Orthovanadate decreases the leptin content in isolated mouse fat pads via proteasome activation. Yoshida A; Hirano K; Motoyashiki T; Morita T; Ueki H Arch Biochem Biophys; 2002 Oct; 406(2):253-60. PubMed ID: 12361713 [TBL] [Abstract][Full Text] [Related]
27. Are factor Xa inhibitors superior to thrombin inhibitors in anticoagulation? Stürzebecher J; Stürzebecher U Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):152-6. PubMed ID: 2459011 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma. Ofosu FA; Choay J; Anvari N; Smith LM; Blajchman MA Eur J Biochem; 1990 Oct; 193(2):485-93. PubMed ID: 2226466 [TBL] [Abstract][Full Text] [Related]
29. Protein S binds to and inhibits factor Xa. Heeb MJ; Rosing J; Bakker HM; Fernandez JA; Tans G; Griffin JH Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2728-32. PubMed ID: 8146182 [TBL] [Abstract][Full Text] [Related]
30. A new C-type lectin (RVsnaclec) purified from venom of Daboia russelii russelii shows anticoagulant activity via inhibition of FXa and concentration-dependent differential response to platelets in a Ca²⁺-independent manner. Mukherjee AK; Dutta S; Mackessy SP Thromb Res; 2014 Nov; 134(5):1150-6. PubMed ID: 25281435 [TBL] [Abstract][Full Text] [Related]
31. Stimulation of endothelial cell proliferation by vanadate is specific for microvascular endothelial cells. Maher PA J Cell Physiol; 1992 Jun; 151(3):549-54. PubMed ID: 1295902 [TBL] [Abstract][Full Text] [Related]
32. SSR182289A, a novel, orally active thrombin inhibitor: in vitro profile and ex vivo anticoagulant activity. Berry CN; Lassalle G; Lunven C; Altenburger JM; Guilbert F; Lalé A; Hérault JP; Lecoffre C; Pfersdorff C; Herbert JM; O'Connor SE J Pharmacol Exp Ther; 2002 Dec; 303(3):1189-98. PubMed ID: 12438543 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of a Src homology 2 domain containing protein tyrosine phosphatase by vanadate in the primary culture of hepatocytes. Pugazhenthi S; Tanha F; Dahl B; Khandelwal RL Arch Biochem Biophys; 1996 Nov; 335(2):273-82. PubMed ID: 8914924 [TBL] [Abstract][Full Text] [Related]
34. The significance of TFPI in clotting assays--comparison and combination with other anticoagulants. Nordfang O; Kristensen HI; Valentin S; Ostergaard P; Wadt J Thromb Haemost; 1993 Sep; 70(3):448-53. PubMed ID: 8259547 [TBL] [Abstract][Full Text] [Related]
35. A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va. Mesters RM; Heeb MJ; Griffin JH Biochemistry; 1993 Nov; 32(47):12656-63. PubMed ID: 8251484 [TBL] [Abstract][Full Text] [Related]
36. Potentiation of twitch contraction in guinea pig ureter by sodium vanadate. Sunano S; Moriyama K; Shimamura K Am J Physiol; 1992 Nov; 263(5 Pt 1):C953-8. PubMed ID: 1443105 [TBL] [Abstract][Full Text] [Related]
37. Orthovanadate both mimics and antagonizes the transforming growth factor beta action on normal rat kidney cells. Rijksen G; Völler MC; Van Zoelen EJ J Cell Physiol; 1993 Feb; 154(2):393-401. PubMed ID: 8425920 [TBL] [Abstract][Full Text] [Related]
38. Insulin-mimetic agents vanadate and pervanadate stimulate glucose but inhibit amino acid uptake. Tsiani E; Abdullah N; Fantus IG Am J Physiol; 1997 Jan; 272(1 Pt 1):C156-62. PubMed ID: 9038821 [TBL] [Abstract][Full Text] [Related]
39. Anticoagulant and anti-platelet activity of polyphenolic-polysaccharide preparation isolated from the medicinal plant Erigeron canadensis L. Pawlaczyk I; Czerchawski L; Kuliczkowski W; Karolko B; Pilecki W; Witkiewicz W; Gancarz R Thromb Res; 2011 Apr; 127(4):328-40. PubMed ID: 21172723 [TBL] [Abstract][Full Text] [Related]
40. Effect of rivaroxaban, in contrast to heparin, is similar in neonatal and adult plasma. Novak M; Schlagenhauf A; Bernhard H; Schweintzger S; Leschnik B; Muntean W Blood Coagul Fibrinolysis; 2011 Oct; 22(7):588-92. PubMed ID: 21799400 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]